Halo Care Skin Tag Remover is a topical cosmetic serum and is not intended to diagnose, treat, cure, or prevent any disease. Consumers should consult a licensed dermatologist before applying any ...
VisioCore Vision Support Supplement Ingredients, Lutein and Zeaxanthin Formula, Pricing, Official Website Access, and 60-Day Guarantee Explained for 2026. Aurora, CO, May 02, 2026 ...
MemoPryl is a daily nootropic supplement made for adults who want to support normal memory function, focus, and mental clarity as part of a healthy cognitive wellness routine. The formula is designed ...
The Milken Institute Global Conference 2026 is set to open tomorrow in Beverly Hills, bringing together a global cross section of leaders from healthcare, finance, technology, and policy for ...
Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived ...
Camilla Sylvest will bring deep commercial expertise to the Board at a critical stage, as Zealand Pharma advances towards establishing its commercial footprint   The final decision to elect Camilla ...
The RSUs will vest in four equal annual installments beginning on the first anniversary of the award's vesting commencement date, subject to such employee's continued service with the Company through ...
The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today that effective May 1 st 2026, ...
How Gala GLP-1's Compounded Tirzepatide and Semaglutide Telehealth Plans Work: Licensed Providers, $179/Mo Pricing, No Insurance Required, and Access in All 50 States in 2026. Wil ...
Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the develop ...
Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for ...
(Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced positive topline results from the PIK3CA mutant cohort of the Phase 3 ...